Accuracy of immunoblotting assay for detection of specific IgE compared with ImmunoCAP in allergic patients
Keywords:
Sensitivity, Specificity, Immunoblotting, Specific IgEAbstract
Background and aim: Standardized techniques help us to better diagnosis and follow up of allergic diseases. In this study, we determined the sensitivity, accuracy, and specificity of an Immunoblotting test compared to ImmunoCAP as the reference in vitro test for detection of specific IgE in allergic patients. Methods: In this cross-sectional study, specific IgE level was determined in patients with allergic symptoms who referred to the Immunology, Asthma and Allergy Research Institute, Tehran, Iran from 2010-2016, by two techniques. Eleven different allergens (six aeroallergens and five food allergens) were determined, and 303 specific IgE tests were performed for the patients by each method. The Immunoblotting test is a multiplex assay on a nitrocellulose membrane coated with 20 selected allergens. ImmunoCAP is considered as the reference method for determination of in vitro specific IgE. Its principle is an automated sandwich immunoassay, and allergens were bound to the solid phase, covalently. Finally, the fluorescence of elute was determined. Specific IgE more than 0.35 KU/L was considered as a positive test. Sensitivity, specificity, accuracy, kappa coefficient, positive and negative likelihood ratio (+/- LR), and correlation coefficient (calculated with Spearman test) between two tests were determined using statistical analysis (SPSS software, version 18). Results: One hundred and thirty five patients entered this study. The median age of the patients was 3.75 years with the males constituting 54.8% of the population. The most common cheif complaints were respiratory (51.6%), skin (41.8%) and gastrointestinal (27.9%) symptoms, respectively. The sensitivity, specificity, accuracy, +LR and -LR were 83%, 97%, 92%, 27.66 and 0.17, respectively. The kappa coefficient of the immunoblotting test was 0.81 compared to the reference technique. The correlation coefficient for positive tests between the two methods was 0.71 (p<0.001). Conclusion: Regarding the presence of 20 allergens in a RIDA allergy panel and according to our findings, this immunoblotting test with high sensitivity could be used as a fast and cost-efficient screening test. However, ImmunoCAP is recommended when the accurate level of specific IgE is required. ImmunoCAP findings are particularly helpful for immunotherapy and the elimination diet.References
Wang J, Godbold JH, Sampson HA. Correlation of serum allergy (IgE) tests performed by different assay
systems. J Allergy Clin Immunol. 2008; 121: 1219-24. doi: 10.1016/j.jaci.2007.12.1150. PMID: 18243289
Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Hilger C, Hofmaier S, et al. EAACI Molecular
Allergology User's Guide. Pediatr Allergy Immunol. 2016; 27 Suppl 23: 1-250. doi: 10.1111/pai.12563.
PMID: 27288833.
Williams PB, Barnes JH, Szeinbach SL, Sullivan TJ. Analytic precision and accuracy of commercial
immunoassays for specific IgE: establishing a standard. J Allergy Clin Immunol. 2000; 105: 1221-30. doi:
1067/mai.2000.105219. PMID: 10856158.
Szeinbach SL, Barnes JH, Sullivan TJ, Williams PB. Precision and accuracy of commercial laboratories'
ability to classify positive and/or negative allergen-specific IgE results. Ann Allergy Asthma Immunol.
; 86: 373-81. doi: 10.1016/S1081-1206(10)62481-7. PMID: 11345278.
Hwang H, Kwon J, Kim JY, Lee HH, Oh CE, Choi GS. The RIDA Allergy Screen Versus the Phadiatop
Test in 430 Consecutive Patient Specimens. Lab Med. 2016; 47(1): 20-9. doi: 10.1093/labmed/lmv002.
PMID: 26732778.
Chong Neto HJ, Rosario NA. Studying specific IgE: in vivo or in vitro. Allergol Immunopathol (Madr).
; 37(1): 31-5. doi: 10.1016/S0301-0546(09)70249-6. PMID: 19268059.
Cox L, Williams B, Sicherer S, Oppenheimer J, Sher L, Hamilton R, et al. Pearls and pitfalls of allergy
diagnostic testing: report from the American College of Allergy, Asthma and Immunology/American
Academy of Allergy, Asthma and Immunology Specific IgE Test Task Force. Ann Allergy Asthma
Immunol. 2008; 101(6): 580-92. doi: 10.1016/S1081-1206(10)60220-7. PMID: 19119701.
Heinzerling L, Mari A, Bergmann KC, Bresciani M, Burbach G, Darsow U, et al. The skin prick test - European standards. Clin Transl Allergy. 2013; 3(1): 3. doi: 10.1186/2045-7022-3-3. PMID: 23369181.
Ihm YK, Kang SY, Kim MH, Lee WI. Chemiluminescent Assay Versus Immunoblotting for Detection of
Positive Reaction to Allergens. Labmedicine. 2012; 43: 91-5. doi: 10.1309/LMK23OPMAVHH3XTI.
Goikoetxea MJ, Sanz ML, Garcia BE, Mayorga C, Longo N, Gamboa PM, et al. Recommendations for the
use of in vitro methods to detect specific immunoglobulin E: are they comparable? J Investig Allergol Clin
Immunol. 2013; 23: 448-54. PMID: 24654308.
Han M, Shin S, Park H, Park KU, Park MH, Song EY. Comparison of three multiple allergen simultaneous
tests: RIDA allergy screen, MAST optigen, and polycheck allergy. Biomed Res Int. 2013; 2013: 340513.
doi: 10.1155/2013/340513. PMID: 23484110.
Park DS, Cho JH, Lee KE, Ko S, Kim HR, Choi SI, et al. Detection rate of allergen-specific IgE by
multiple antigen simultaneous test-immunoblot assay. Korean J Lab Med. 2004; 24: 131-8.
Oh EJ, Lee SA, Lim J, Park YJ, Han K, Kim Y. Detection of allergen specific IgE by AdvanSure Allergy
Screen test. Korean J Lab Med. 2010; 30(4):420-31. doi: 10.3343/kjlm.2010.30.4.420. PMID: 20805716.
Derived from; https://clinical.r-biopharm.com/products/rida-qline-allergy-panel-2-3-1/.
Hamilton RG. Clinical laboratories worldwide need to report IgE antibody results on clinical specimens as
analytical results and not use differential positive thresholds. J Allergy Clin Immunol. 2015; 136: 811-2.
doi: 10.1016/j.jaci.2015.03.002. PMID: 25863980.
Park KH, Lee J, Lee SC, Son YW, Sim DW, Lee JH, et al. Comparison of the ImmunoCAP Assay and
AdvanSure™ AlloScreen Advanced Multiplex SpecificIgE Detection Assay. Yonsei Med J. 2017; 58(4):
-92. doi: 10.3349/ymj.2017.58.4.786. PMID: 28540992, PMCID: PMC5447110.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.